Evolent Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Evolent Health, Inc. on October 28, 2021, with a report date of November 3, 2021. The filing primarily addresses corporate governance changes and references the announcement of financial results for the quarter ended September 30, 2021.
Key Financial Metrics
The filing references a press release (Exhibit 99.1) containing financial results for the quarter ended September 30, 2021. However, the text of this 8-K does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the referenced press release for detailed financial data.
Material Changes and Corporate Governance
- Board Departure: Mr. Michael D'Amato retired from the Board of Directors on October 28, 2021. The retirement was not the result of any disagreement with the Company.
- Board Appointment: Dr. Tunde Sotunde was appointed to the Board as a Class II director (term expiring at the 2023 Annual Meeting). Dr. Sotunde was also appointed to the Audit Committee and the Compliance and Regulatory Affairs Committee and is deemed an independent director.
- Executive Transition: Mr. Frank Williams will transition from Executive Chairman to non-executive Chairman of the Board, effective January 1, 2022.
Guidance, Outlook, and Risks
The filing does not contain specific guidance, outlook, or management commentary regarding future financial performance. It notes that the information furnished under Item 2.02 (Results of Operations) and Item 7.01 (Regulation FD Disclosure) is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the specific financial results for the quarter ended September 30, 2021, by reviewing the press release dated November 3, 2021 (Exhibit 99.1), as this 8-K does not list the figures.
- Confirm the effective date of Mr. Frank Williams' transition to non-executive Chairman (January 1, 2022).
- Note that Dr. Tunde Sotunde's appointment includes membership on the Audit and Compliance committees.